Skip to main content

Accelerating market introduction of the first real-time diagnistic and monitoring device for upper gastrointestinal bleeding (UGIB)

Project description

Sensor technology for detection and monitoring of upper gastrointestinal bleeding

Upper gastrointestinal bleeding (UGIB) is a life-threatening emergency resulting in 2 million hospitalisations each year in Europe and the United States. The Irish company EnteraSense is developing an innovative sensor technology to detect and monitor UGIB. A capsule containing the sensor is ingested in the same way as existing capsules in the market today. The optical-based sensor acquires data from the environment during its transit along the gastrointestinal tract. The data are processed to determine the presence of blood and to send a signal to an external monitor. This technology will significantly enhance the diagnostic capabilities of gastrointestinal physicians. The current EU-funded PillSense project aims to optimise the product design, develop a commercial manufacturing process, and gain clinical approval through two stages of in-human clinical trials.

Coordinator

ENTERASENSE LIMITED
Net EU contribution
€ 1 366 734,75
Address
Penn Engineering Mervue Business And Technology Pa
H91D3T0 Galway
Ireland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 585 743,46
Region
Ireland Northern and Western West
 

Participants (5)

ANECTO LIMITED

Participation ended

Ireland
Net EU contribution
€ 0,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Penn Engineering, Mervue Business & Technology Par
H91D3T0 Galway
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
Region
Ireland Northern and Western West
 
STERIPACK MEDICAL POLAND SP ZOO
Poland
Net EU contribution
€ 554 400,00
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Ul. Japonska 1 Leg
55 220 Jelcz Laskowice
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 237 600,00
FAKULTNI NEMOCNICE OSTRAVA

Participation ended

Czechia
Net EU contribution
€ 0,00
Address
17 Listopadu 1790
708 52 Ostrava Poruba
Activity type
Research Organisations
Non-EU contribution
€ 0,00
PHARMNET S.R.O.
Czechia
Net EU contribution
€ 295 596,50
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Hrncirum 20
14900 Praha
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 126 684,21
Region
Praha Hlavní město Praha
 
SYNERGY HEALTH IRELAND LIMITED
Ireland
Net EU contribution
€ 459 025,00
Address
Ida Business & Technology Park
Dublin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 196 725,00
Region
Ireland Eastern and Midland Dublin